With Blackstone’s $300m, Uniquity Will Take On Tezspire In Respiratory Disease

 
• By Joseph Haas
  
Lungs
Uniquity plans to compete with Tezspire in respiratory disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business